Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Serum salicylate levels and risk of recurrent colorectal adenomas.

Shaukat A, Grau MV, Church TR, Baxter G, Barry EL, Summers R, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):679-82. doi: 10.1158/1055-9965.EPI-10-1135. Epub 2011 Feb 9.

2.

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP.

Cancer Prev Res (Phila). 2010 Dec;3(12):1552-64. doi: 10.1158/1940-6207.CAPR-10-0047.

3.

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.

Levine AJ, Grau MV, Mott LA, Ueland PM, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2541-8. doi: 10.1158/1055-9965.EPI-10-0536. Epub 2010 Sep 14.

4.

Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.

Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, Chen L, Harris R, Davis M, Marsden G, Johnston C, Lane JA, Ebbing M, Bønaa KH, Nygård O, Ueland PM, Grau MV, Baron JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1632-42. doi: 10.1158/1055-9965.EPI-10-0180. Epub 2010 May 25. Review.

5.

Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. doi: 10.1158/1055-9965.EPI-09-0363. Epub 2009 Sep 15.

6.

The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, Gui J, Barry EL, Summers RW, McKeown-Eyssen G, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2310-7. doi: 10.1158/1055-9965.EPI-09-0211.

7.

Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.

Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1041-9. doi: 10.1158/1055-9965.EPI-08-0926. Epub 2009 Mar 31.

8.

Folic acid and risk of prostate cancer: results from a randomized clinical trial.

Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA.

J Natl Cancer Inst. 2009 Mar 18;101(6):432-5. doi: 10.1093/jnci/djp019. Epub 2009 Mar 10.

9.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484. Epub 2009 Feb 10.

10.

Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2625-31. doi: 10.1158/1055-9965.EPI-08-0382.

11.

Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2136-45. doi: 10.1158/1055-9965.EPI-07-2895.

12.

Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial.

Bischoff-Ferrari HA, Rees JR, Grau MV, Barry E, Gui J, Baron JA.

Am J Clin Nutr. 2008 Jun;87(6):1945-51.

13.

Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge.

Lacy BE, Weiser K, Noddin L, Robertson DJ, Crowell MD, Parratt-Engstrom C, Grau MV.

Aliment Pharmacol Ther. 2007 Jun 1;25(11):1329-41.

14.

Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.

Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, Beck GJ, Summers RW, Barry EL, Cole BF, Snover DC, Rothstein R, Mandel JS.

J Natl Cancer Inst. 2007 Jan 17;99(2):129-36.

PMID:
17227996
15.

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG.

J Natl Cancer Inst. 2006 Oct 18;98(20):1494-500. Erratum in: J Natl Cancer Inst. 2006 Dec 20;98(24):1828.

PMID:
17047198
17.

Chemoprevention in gastrointestinal cancers: current status.

Grau MV, Rees JR, Baron JA.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):281-7. Review.

18.

Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.

Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, Stukel TA, Mandel JS.

Int J Cancer. 2006 Aug 1;119(3):682-6.

19.

K-ras mutations in incident sporadic colorectal adenomas.

Barry EL, Baron JA, Grau MV, Wallace K, Haile RW.

Cancer. 2006 Mar 1;106(5):1036-40.

20.

Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.

Grau MV, Baron JA, Barry EL, Sandler RS, Haile RW, Mandel JS, Cole BF.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2353-8.

21.

Risk of prostate cancer in a randomized clinical trial of calcium supplementation.

Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS, Heber D, Greenberg ER.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):586-9.

22.

Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.

Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D.

J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71.

PMID:
14652238

Supplemental Content

Support Center